Real-time enrollment status for this aml clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 1:57 AM UTC
| NCT Number | NCT06001788 |
| Recruiting Status | Recruiting |
| Condition | AML |
| Phase | PHASE1 |
| Target Enrollment | 171 participants |
| Active Locations | 38 sites in the US |
| Sponsor | Kura Oncology, Inc. |
| Last Updated on CT.gov | August 20, 2026 (1 week ago) |
As of August 28, 2026: Clinical trial NCT06001788 is currently recruiting participants. This phase1 study for aml is actively seeking new participants at 38 locations across the United States. The study is sponsored by Kura Oncology, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06001788 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 38 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06001788 was last updated 1 week ago (August 20, 2026). HelloStudys verifies this status automatically.